Gaudi Cathedral, Barcelona

It seems oddly surreal of my photo editor to remind me that on this day in the past we were in Barcelona (right) for some conference or other and this year’s EORTC-NCI-AACR Molecular Targets meeting (aka the Triple in industry parlance) was cancelled in Spain in favour of a virtual meeting, thanks to the ongoing pandemic.

There is no doubt that thinking big in cancer research is vitally important, but sometimes we have to consider the difference between building cathedrals for the long-term rather than building simple walls as short-term fixes.

Here we consider some examples in the context of oncology drug development and also open the monthly October BSB mailbag…

To learn more from our oncology analysis and get a heads up on the latest insights and commentary pertaining to the EORTC-NCI-AACR Triple meeting, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by